Jan A. Falch
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jan A. Falch has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Asle Wilhelm Medhus
Institute of Clinical Medicine, University of Oslo , Oslo
1 shared publication - Cathrine M Lofthus
Faculty of Medicine, University of Oslo, Klaus Torgårds vei 3, Oslo, N-0372, Norway
1 shared publication - Erik Fink Eriksen
Spesialistsenteret Pilestredet Park and Department of Odontology, University of Oslo, 0315 Oslo, Norway
1 shared publication - Haakon E. Meyer
Department of Community Medicine and Global Health, Institute of Health and Society, University of Oslo, 0318 Oslo, Norway
1 shared publication - Lena Lande Wekre
TRS National Resource Centre for Rare Disorders, Sunnaas Rehabilitation Hospital and the University of Oslo, Nesoddtangen, Norway
1 shared publication - Tore Wentzel-Larsen
Centre for Child and Adolescent Mental Health, Eastern and Southern Norway, Gullhaug Torg 4B, Oslo, N-0484, Norway
1 shared publication
Latest Publications
- Open Access
- 13 March 2013
- Published by Springer Nature in BMC Geriatrics
- Vol. 13 (1) , 25
Secular reduction of excess mortality in hip fracture patients >85 years
More than 20% of the hip fracture patients die within the first year after the incident. Few data are available on the trends in mortality following a hip fracture. The present aim was to study changes in excess mortality after hip fracture from 1978/79 up to 1996/97.
- 13 March 2013
- Published by Springer Nature in BMC Geriatrics
- Vol. 13 (1) , 25
Open AccessSecular reduction of excess mortality in hip fracture patients >85 years
More than 20% of the hip fracture patients die within the first year after the incident. Few data are available on the trends in mortality following a hip fracture. The present aim was to study changes in excess mortality after hip fracture from 1978/79 up to 1996/97.
- Open Access
- 14 April 2011
- Published by Springer Nature in Archives of Osteoporosis
- Vol. 6 (1-2) , 31-38
Bone mass, bone markers and prevalence of fractures in adults with osteogenesis imperfecta
Summary Still little is known about the manifestations of osteogenesis imperfecta (OI) in adults. We therefore initiated this study of bone mass, bone turnover and prevalence of fractures in a large cohort of adult patients. We found a surprising low prevalence (10%) of osteoporosis. These patients, however, expressed the most severe disease. Purpose To characterize bone mineral density, bone turnover, calcium metabolism and prevalence of fractures in a large cohort of adults with osteogenesis imperfecta. Methods One hundred fifty-four patients with adult OI participated and 90 (age range 25–83) provided dual X-ray absorptiometry (DXA) measurements. According to Sillence classification criteria, 68 persons were classified as OI type I, 9 as type III, 11 type IV and 2 were unclassified. Fracture numbers were based on self-reporting. Biochemical markers of bone turnover were measured and bone mineral density (BMD) of the spine, femoral neck and total body were determined by DXA. Results Only 10% of adults with OI exhibited osteoporotic T scores (T ≤ −2.5) but compared to patients with normal T scores this subgroup had a threefold higher fracture risk (22 vs. 69). s-PTH, s-Ca and 25[OH] vitamin D were all normal. Bone markers did not display major deviations from normal, but patients with OI type III displayed higher resorption marker levels than type I and IV. Multivariate regression analysis showed that only gender and total body BMD were significant determinants of fracture susceptibility, and the differences for total body BMC, BMD and Z scores were significant between the OI subtypes. Conclusions In adult OI, DXA measurements only identified few patients as osteoporotic. These patients, however, exhibited a much higher fracture propensity. Due to deformities, low body height and pre-existing fractures, DXA assessment is complicated in this disease, and further studies are needed to work out how to minimize the impact of these confounders.
- 14 April 2011
- Published by Springer Nature in Archives of Osteoporosis
- Vol. 6 (1-2) , 31-38
Open AccessBone mass, bone markers and prevalence of fractures in adults with osteogenesis imperfecta
Summary Still little is known about the manifestations of osteogenesis imperfecta (OI) in adults. We therefore initiated this study of bone mass, bone turnover and prevalence of fractures in a large cohort of adult patients. We found a surprising low prevalence (10%) of osteoporosis. These patients, however, expressed the most severe disease. Purpose To characterize bone mineral density, bone turnover, calcium metabolism and prevalence of fractures in a large cohort of adults with osteogenesis imperfecta. Methods One hundred fifty-four patients with adult OI participated and 90 (age range 25–83) provided dual X-ray absorptiometry (DXA) measurements. According to Sillence classification criteria, 68 persons were classified as OI type I, 9 as type III, 11 type IV and 2 were unclassified. Fracture numbers were based on self-reporting. Biochemical markers of bone turnover were measured and bone mineral density (BMD) of the spine, femoral neck and total body were determined by DXA. Results Only 10% of adults with OI exhibited osteoporotic T scores (T ≤ −2.5) but compared to patients with normal T scores this subgroup had a threefold higher fracture risk (22 vs. 69). s-PTH, s-Ca and 25[OH] vitamin D were all normal. Bone markers did not display major deviations from normal, but patients with OI type III displayed higher resorption marker levels than type I and IV. Multivariate regression analysis showed that only gender and total body BMD were significant determinants of fracture susceptibility, and the differences for total body BMC, BMD and Z scores were significant between the OI subtypes. Conclusions In adult OI, DXA measurements only identified few patients as osteoporotic. These patients, however, exhibited a much higher fracture propensity. Due to deformities, low body height and pre-existing fractures, DXA assessment is complicated in this disease, and further studies are needed to work out how to minimize the impact of these confounders.